REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) — Institutional Holders, Q2 2026

5 institutional investment managers reported a RVPH position on SEC Form 13F-HR for the quarter ended June 30, 2026, with a combined reported value of $3.7K. Every filer is listed below, ranked by position value. Put and call option positions are excluded, and a firm filing several lots or share classes is shown once with its total.

RVPH in Q2 2026: what funds did

Funds that filed a 13F for both Q1 2026 and Q2 2026, by what they did with the common stock. Share counts are adjusted for any split between the two quarters; dollar figures are the change in shares at this quarter’s price.

New positions

2

Added to

0

Trimmed

0

Sold out

33

Biggest buyers

  1. Mosley Wealth ManagementNew · +1 sh+$1.00
  2. Miller Global InvestmentsNew · +1 sh+$1.00

Biggest sellers

  1. MILLENNIUM MANAGEMENTSold out · -793,948 sh-$523.4K
  2. HIGHBRIDGE CAPITAL MANAGEMENTSold out · -762,236 sh-$502.5K
  3. ARMISTICE CAPITALSold out · -592,079 sh-$390.3K
  4. GSA CAPITAL PARTNERS LLPSold out · -261,898 sh-$172.6K
  5. VANGUARD CAPITAL MANAGEMENTSold out · -117,568 sh-$77.5K

RVPH 13F holders ranked 1–5 of 5

Institutional investors reporting a position in REVIVA PHARMACEUTICALS HOLDINGS, INC. on SEC Form 13F-HR for Q2 2026, ranked by reported value.
InstitutionValueQoQ
EMC Capital Management#1 · 6,696 sh$3.0K—
TD Waterhouse Canada#2 · 625 sh$412.000.0%
Purpose Unlimited#3 · 405 sh$259.000.0%
Mosley Wealth Management#4 · 1 sh$1.00New
Miller Global Investments#5 · 1 sh$1.00New

Funds that sold out of RVPH in Q2 2026 (33)

Held RVPH at the end of Q1 2026 and filed a Q2 2026 13F without it. Not in the list above, because they no longer hold it. Largest prior position first.

Institutions that held RVPH in Q1 2026 and reported no position in Q2 2026.
InstitutionValue in Q1 2026
MILLENNIUM MANAGEMENT793,948 sh$579.3K
HIGHBRIDGE CAPITAL MANAGEMENT762,236 sh$556.2K
ARMISTICE CAPITAL592,079 sh$432.0K
GSA CAPITAL PARTNERS LLP261,898 sh$191.0K
VANGUARD CAPITAL MANAGEMENT117,568 sh$85.8K
Warberg Asset Management90,772 sh$66.2K
GEODE CAPITAL MANAGEMENT72,992 sh$53.3K
RENAISSANCE TECHNOLOGIES43,002 sh$31.4K
Virtu Financial32,905 sh$24.0K
VANGUARD FIDUCIARY31,598 sh$23.1K
STATE STREET19,160 sh$14.0K
BlackRock18,582 sh$13.6K
HRT FINANCIAL18,423 sh$13.0K
Castleview Partners15,694 sh$11.5K
TWO SIGMA INVESTMENTS10,715 sh$7.8K
NORTHERN10,469 sh$7.6K
MORGAN STANLEY8,530 sh$6.2K
UBS Group AG5,269 sh$3.8K
Vanguard Global Advisers3,115 sh$2.3K
GROUP ONE TRADING, L.P.3,109 sh$2.3K
Tower Research Capital (TRC)2,193 sh$1.6K
Sound Income Strategies1,500 sh$1.2K
OSAIC1,219 sh$889.00
Larson Financial Group833 sh$608.00
NORTHWESTERN MUTUAL WEALTH MANAGEMENT470 sh$343.00
SBI Securities , Ltd.250 sh$182.00
IFP Advisors200 sh$146.00
WELLS FARGO & COMPANY150 sh$109.00
Vermillion Wealth Management50 sh$40.00
Activest Wealth Management50 sh$36.00
Tradewinds Capital Management13 sh$10.00
DANSKE BANK A/S7 sh$5.00
ROYAL BANK OF CANADA75 sh$0.00

Source: Form 13F-HR filings on SEC EDGAR, Q2 2026. Values are as reported by each manager at quarter end. “% of portfolio” is the position’s share of the manager’s total reported 13F value for the same quarter. “New” means the manager filed a 13F for Q1 2026 without this position; a dash means no comparison is available. Where a manager’s own filing is internally inconsistent its value is withheld and it is listed last. 13F data shows reported holdings, not recommendations.